In metabolic disorders such as gestational diabetes mellitus (GDM), changes in complement components like C3 and C4 levels are closely related to lipid metabolism abnormalities, promoting low-grade chronic inflammation, vascular injury, and thrombosis, thereby increasing the risk of cardiovascular diseases [45]. This evidence concerns the gene C4A and gestational diabetes.